Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis-Reference-Cited by-同舟云学术

Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis

Published:2018-10 Issue:10 Volume:44 Page:1619-1623
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Barenboim Alex,Lahat Guy,Geva Ravit,Nachmany Ido,Nakache Richard,Goykhman Yaacov,Brazowski Eli,Rosen Galia,Isakov Ofer,Wolf Ido,Klausner Joseph M.,Lubezky Nir

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference21 articles.

1. Annual report to the nation on the status of cancer, 1975–2008, featuring cancers associated with excess weight and lack of sufficient physical activity;Eheman;Cancer,2012

2. Prognostic indicators for survival after resection of pancreatic adenocarcinoma;Geer;Am J Surg,1993

3. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines;Tempero;J Natl Compr Cancer Netw JNCCN,2014

4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Vaccaro;N Engl J Med,2011

5. Resection of locally advanced pancreatic cancer without regression of arterial encasement after modern-era neoadjuvant therapy;Kluger;J Gastrointest Surg,2018

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allysine-Targeted Molecular MRI Enables Early Prediction of Chemotherapy Response in Pancreatic Cancer;Cancer Research;2024-05-17

2. Targeting mucins for fluorescence-guided surgery of pancreatic cancer;Molecular-Guided Surgery: Molecules, Devices, and Applications X;2024-03-13

3. Combination of modified FOLFIRINOX with stereotactic body radiotherapy as an induction therapy for locally advanced pancreatic adenocarcinoma – a prospective single-arm study;Współczesna Onkologia;2024

4. Pankreaskarzinom und zystische Neoplasien im Pankreas;Therapie-Handbuch - Gastroenterologie und Hepatologie;2024

5. Pankreaskarzinom und zystische Neoplasien im Pankreas;Therapie-Handbuch - Onkologie und Hämatologie;2024